Mirador Capital Partners LP - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mirador Capital Partners LP ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$1,638,801
-6.5%
55,628
+3.5%
0.37%
-10.3%
Q2 2023$1,752,934
-12.0%
53,738
-5.0%
0.42%
-11.9%
Q1 2023$1,991,191
-26.0%
56,584
-3.7%
0.47%
-25.8%
Q4 2022$2,691,100
-56.8%
58,732
-54.3%
0.64%
-57.6%
Q3 2022$6,225,000
-3.1%
128,485
-21.5%
1.50%
-1.1%
Q2 2022$6,427,000
+9.5%
163,583
+2.6%
1.52%
+27.7%
Q1 2022$5,871,000
-15.6%
159,498
+4.5%
1.19%
-18.9%
Q4 2021$6,956,000
+19.0%
152,619
-6.6%
1.46%
+10.5%
Q3 2021$5,843,000
+86.3%
163,476
+3.1%
1.33%
+86.8%
Q2 2021$3,137,000
-9.5%
158,499
+6.3%
0.71%
-20.2%
Q1 2021$3,468,000
+9.5%
149,084
-2.2%
0.89%
+2.4%
Q4 2020$3,167,000
+30.5%
152,395
+35.9%
0.87%
+14.9%
Q3 2020$2,427,000
+7.2%
112,124
+16.7%
0.76%
-10.7%
Q2 2020$2,265,000
+39.9%
96,107
-1.3%
0.85%
+25.3%
Q1 2020$1,619,000
+48.9%
97,354
-5.0%
0.68%
+54.3%
Q4 2019$1,087,000102,4760.44%
Other shareholders
CYTOKINETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders